Locoregional treatments before liver transplantation for hepatocellular carcinoma: a study from the European Liver Transplant Registry

Transplant International

Volumn 31, Issue 5, 2018, Pages 531-539

  Pommergaard, Hans Christian ^a   Rostved, Andreas Arendtsen ^a   Adam, René ^b   Thygesen, Lau Caspar ^c   Salizzoni, Mauro ^d   Gómez Bravo, Miguel Angel ^e   Cherqui, Daniel ^b   De Simone, Paolo ^f   Boudjema, Karim ^g,h   Mazzaferro, Vincenzo ⁱ   Soubrane, Olivier ^j   García Valdecasas, Juan Carlos ^k   Fabregat Prous, Joan ^l   Pinna, Antonio D ^m   O'Grady, John ⁿ   Karam, Vincent ^b   Duvoux, Christophe ^o   Rasmussen, Allan ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b HÔPITAL PAUL BROUSSE   (France)

^c UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^d MOLINETTE HOSPITAL   (Italy)

^e HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

^f UNIVERSITY HOSPITAL OF PISA   (Italy)

^g PONTCHAILLOU UNIVERSITY HOSPITAL   (France)

^h INSERM   (France)

ⁱ UNIVERSITY OF MILAN   (Italy)

^j BEAUJON HOSPITAL   (France)

^k HOSPITAL CLÍNIC   (Spain)

^l HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^m UNIVERSITY OF BOLOGNA   (Italy)

ⁿ KING S COLLEGE HOSPITAL   (United Kingdom)

^o HENRI MONDOR HOSPITAL   (France)

more..

Author keywords

hepatocellular carcinoma; liver transplantation; locoregional treatment; pretreatment

Indexed keywords

ANTINEOPLASTIC AGENT;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER CLASSIFICATION; CANCER PROGNOSIS; CANCER REGISTRY; CANCER SURGERY; CANCER SURVIVAL; CANCER TRANSPLANTATION; CHEMOEMBOLIZATION; CHILD; CLINICAL PROTOCOL; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE SEVERITY; EUROPEAN; FEMALE; HUMAN; INFANT; LIVER CELL CARCINOMA; LIVER RESECTION; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; NEWBORN; OVERALL SURVIVAL; PRIORITY JOURNAL; RADIOFREQUENCY ABLATION; REGIONAL PERFUSION; RETROSPECTIVE STUDY; CATHETER ABLATION; HOSPITAL ADMISSION; LIVER TUMOR; MIDDLE AGED; MORTALITY; PATHOLOGY; PRESCHOOL CHILD; PROPORTIONAL HAZARDS MODEL; REGISTER; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; CARCINOMA, HEPATOCELLULAR; CATHETER ABLATION; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; LIVER NEOPLASMS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; REGISTRIES; WAITING LISTS; YOUNG ADULT;

EID: 85042223189     PISSN: 09340874     EISSN: 14322277     Source Type: Journal    
DOI: 10.1111/tri.13123     Document Type: Article

References (24)

1. Wiesner RH, Freeman RB, Mulligan DC. Liver transplantation for hepatocellular cancer: the impact of the MELD allocation policy. Gastroenterology 2004; 127: S261.
2. Fontana RJ, Hamidullah H, Nghiem H, et al. Percutaneous radiofrequency thermal ablation of hepatocellular carcinoma: a safe and effective bridge to liver transplantation. Liver Transpl 2002; 8: 1165.
3. Harnois DM, Steers J, Andrews JC, et al. Preoperative hepatic artery chemoembolization followed by orthotopic liver transplantation for hepatocellular carcinoma. Liver Transpl Surg 1999; 5: 192.
4. Lee MW, Raman SS, Asvadi NH, et al. Radiofrequency ablation of hepatocellular carcinoma as bridge therapy to liver transplantation: a ten year intention-to-treat analysis. Hepatology 2017; 65: 1979.
5. Yao FY, Mehta N, Flemming J, et al. Downstaging of hepatocellular cancer before liver transplant: long-term outcome compared to tumors within Milan criteria. Hepatology 2015; 61: 1968.
6. Ravaioli M, Grazi GL, Piscaglia F, et al. Liver transplantation for hepatocellular carcinoma: results of down-staging in patients initially outside the Milan selection criteria. Am J Transplant 2008; 8: 2547.
7. Otto G, Herber S, Heise M, et al. Response to transarterial chemoembolization as a biological selection criterion for liver transplantation in hepatocellular carcinoma. Liver Transpl 2006; 12: 1260.
8. Mazzaferro V. Squaring the circle of selection and allocation in liver transplantation for HCC: an adaptive approach. Hepatology 2016; 63: 1707.
9. Ayaru L, Pereira SP, Alisa A, et al. Unmasking of alpha-fetoprotein-specific CD4(+) T cell responses in hepatocellular carcinoma patients undergoing embolization. J Immunol 2007; 178: 1914.
10. Mizukoshi E, Nakamoto Y, Arai K, et al. Comparative analysis of various tumor-associated antigen-specific t-cell responses in patients with hepatocellular carcinoma. Hepatology 2011; 53: 1206.
11. Zerbini A, Pilli M, Laccabue D, et al. Radiofrequency thermal ablation for hepatocellular carcinoma stimulates autologous NK-cell response. Gastroenterology 2010; 138: 1931.
12. Yao FY, Ferrell L, Bass NM, et al. Liver transplantation for hepatocellular carcinoma: expansion of the tumor size limits does not adversely impact survival. Hepatology 2001; 33: 1394.
13. Regalia E, Coppa J, Pulvirenti A, et al. Liver transplantation for small hepatocellular carcinoma in cirrhosis: analysis of our experience. Transplant Proc 2001; 33: 1442.
14. Oldhafer KJ, Chavan A, Fruhauf NR, et al. Arterial chemoembolization before liver transplantation in patients with hepatocellular carcinoma: marked tumor necrosis, but no survival benefit? J Hepatol 1998; 29: 953.
15. Mazzaferro V, Regalia E, Doci R, et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 1996; 334: 693.
16. Yao FY, Kinkhabwala M, LaBerge JM, et al. The impact of pre-operative loco-regional therapy on outcome after liver transplantation for hepatocellular carcinoma. Am J Transplant 2005; 5: 795.
17. von Elm E, Altman DG, Egger M, et al. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. J Clin Epidemiol 2008; 61: 344.
18. Schemper M, Smith TL. A note on quantifying follow-up in studies of failure time. Control Clin Trials 1996; 17: 343.
19. Majno PE, Adam R, Bismuth H, et al. Influence of preoperative transarterial lipiodol chemoembolization on resection and transplantation for hepatocellular carcinoma in patients with cirrhosis. Ann Surg 1997; 226: 688; discussion-3.
20. De Luna W, Sze DY, Ahmed A, et al. Transarterial chemoinfusion for hepatocellular carcinoma as downstaging therapy and a bridge toward liver transplantation. Am J Transplant 2009; 9: 1158.
21. Brown KT, Do RK, Gonen M, et al. Randomized trial of hepatic artery embolization for hepatocellular carcinoma using doxorubicin-eluting microspheres compared with embolization with microspheres alone. J Clin Oncol 2016; 34: 2046.
22. Feng K, Yan J, Li X, et al. A randomized controlled trial of radiofrequency ablation and surgical resection in the treatment of small hepatocellular carcinoma. J Hepatol 2012; 57: 794.
23. Huang J, Yan L, Cheng Z, et al. A randomized trial comparing radiofrequency ablation and surgical resection for HCC conforming to the Milan criteria. Ann Surg 2010; 252: 903.
24. Allard MA, Sebagh M, Ruiz A, et al. Does pathological response after transarterial chemoembolization for hepatocellular carcinoma in cirrhotic patients with cirrhosis predict outcome after liver resection or transplantation? J Hepatol 2015; 63: 83.